Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)

Intensive Care Medicine

Volumn 40, Issue 9, 2014, Pages 1303-1312

  Lortholary, Olivier ^a,b   Renaudat, Charlotte ^a   Sitbon, Karine ^a   Madec, Yoann ^a   Denoeud Ndam, Lise ^a   Wolff, Michel ^c   Fontanet, Arnaud ^a,d   Bretagne, Stéphane ^a,e   Dromer, Françoise ^a   Bouges Michel, C ^f   Poilane, I ^g   Dunan, J ^h   Galeazzi, G ⁱ   Alanio, A ^j   Foulet, F ^j   Fauchet, N ^k   Forget, E ^l   Lawrence, C ^m   Angoulvant, A ⁿ   Bonnal, C ⁿ   Hennequin, C ⁿ   Botterel, F ⁿ   Eloy, O ^o   David, M F ^p   Khassis, N ^p   Milhaila, L ^p   Chachaty, E ^q   Chochillon, C ^c   Lesle, F ^r   Paugam, A ^r   Baixench, M T ^r   Escande, M C ^s   Cornet, M ^t   Bougnoux, M E ^b   Sterckers, Y ^b   Challier, S ^b   Dannaoui, E ^u   Lavarde, V ^u   Datry, A ^v   Mimouni, B L ^v   Brun, S ^v   Fekkar, A ^v   Guitard, J ^w   Poirot, J L ^w   Lacroix, C ^e   Moissenet, D ^x   Develoux, M ^y   Mariani, P ^z   Bonacorsi, S ^z   Desnos Ollivier, Marie ^aa   Garcia Hermoso, Dea ^aa   Hoinard, Damien ^aa   Raoux, Dorothée ^aa   more..

^a INSTITUT PASTEUR   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c BICHAT HOSPITAL   (France)

^d Bioinformatique et Chimie Moléculaire   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f AVICENNE HOSPITAL   (France)

^g HÔPITAL JEAN VERDIER   (France)

^h HÔPITAL AMBROISE PARÉ   (France)

ⁱ HÔPITAL LOUIS MOURIER   (France)

^j HENRI MONDOR HOSPITAL   (France)

^k Centre Intercommunal   (France)

^l BEAUJON HOSPITAL   (France)

^m RAYMOND POINCARÉ HOSPITAL   (France)

ⁿ BICÊTRE HOSPITAL   (France)

^o CENTRE HOSPITALIER   (France)

^p HÔPITAL PAUL BROUSSE   (France)

^q INSTITUT GUSTAVE ROUSSY   (France)

^r Hôpital Cochin ^*  (France)

^s INSTITUT CURIE   (France)

^t Hotel Dieu   (France)

^u HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^v PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^w HÔPITAL SAINT ANTOINE   (France)

^x SERVICE DE DERMATOLOGIE   (France)

^y HÔPITAL TENON   (France)

^z HÔPITAL ROBERT DEBRÉ   (France)

^aa National Reference Center for Invasive Mycoses and Antifungals   (France)

more..

Author keywords

Candida; Echinocandins; Epidemiology; Fluconazole; Hematological malignancy; Intensive care unit; Non albicans species; Risk factors

Indexed keywords

CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; ANTIFUNGAL AGENT;

ADULT; AGE; AGED; ARTICLE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; DRUG EXPOSURE; FEMALE; FRANCE; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; KLUYVEROMYCES MARXIANUS; MALE; MORTALITY; NONHUMAN; COMPARATIVE STUDY; MIDDLE AGED; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDEMIA; FEMALE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PARIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84906938753     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-014-3408-3     Document Type: Article

References (42)

1. Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, Calandra T, Glauser MP, Tauber MG, Pittet D (2004) Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis 38:311-320 (Pubitemid 38200105)
2. Marra AR, Camargo LF, Pignatari AC, Sukiennik T, Behar PR, Medeiros EA, Ribeiro J, Girao E, Correa L, Guerra C, Brites C, Pereira CA, Carneiro I, Reis M, de Souza MA, Tranchesi R, Barata CU, Edmond MB (2011) Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol 49:1866-1871
3. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309-317 (Pubitemid 39050477)
4. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C (2005) The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 41:1232-1239 (Pubitemid 41532664)
5. Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133-163 (Pubitemid 46167771)
6. Arendrup MC, Sulim S, Holm A, Nielsen L, Nielsen SD, Knudsen JD, Drenck NE, Christensen JJ, Johansen HK (2011) Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol 49:3300-3308
7. Cleveland AA, Farley MM, Harrison LH, Stein B, Hollick R, Lockhart SR, Magill SS, Derado G, Park BJ, Chiller TM (2012) Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis 55:1352-1361
8. Kollef M, Micek S, Hampton N, Doherty JA, Kumar A (2012) Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 54:1739-1746
9. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48:503-535
10. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Florl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ (2012) ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18(Suppl 7):19-37
11. Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, Lichtenberg DA, Chawla V, Young JA, Hadley S (2008) Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med 36:1993-1998
12. Sipsas NV, Lewis RE, Tarrand J, Hachem R, Rolston KV, Raad II, Kontoyiannis DP (2009) Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 115:4745-4752
13. Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C (2011) Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS ONE 6:e24198
14. Arendrup MC, Dzajic E, Jensen RH, Johansen HK, Kjaeldgaard P, Knudsen JD, Kristensen L, Leitz C, Lemming LE, Nielsen L, Olesen B, Rosenvinge FS, Roder BL, Schonheyder HC (2013) Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme. Clin Microbiol Infect 19:E343-E353
15. Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, Dromer F (2011) Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob Agents Chemother 55:532-538
16. Bassetti M, Righi E, Ansaldi F, Merelli M, Cecilia T, De Pascale G, Diaz-Martin A, Luzzati R, Rosin C, Lagunes L, Trecarichi EM, Sanguinetti M, Posteraro B, Garnacho-Montero J, Sartor A, Rello J, Rocca GD, Antonelli M, Tumbarello M (2014) A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med 40:839-845
17. Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, Collins CD, Nagel JL (2013) Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis 57:1237-1245
18. Leon C, Ostrosky-Zeichner L, Schuster M (2014) What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Med 40:808-819
19. Asmundsdottir LR, Erlendsdottir H, Gottfredsson M (2013) Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011. J Clin Microbiol 51:841-848
20. Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, Baughman W, Stein B, Hollick R, Park BJ, Chiller T (2012) Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two US cities from 2008 to 2011. J Clin Microbiol 50:3435-3442
21. Pfaller M, Neofytos D, Diekema D, Azie N, Meier-Kriesche HU, Quan SP, Horn D (2012) Epidemiology and outcomes of candidemia in 3648 patients: data from the prospective antifungal therapy (PATH Alliance®) registry, 2004-2008. Diagn Microbiol Infect Dis 74:323-331
22. Almirante B, Rodriguez D, Park BJ, Cuenca-Estrella M, Planes AM, Almela M, Mensa J, Sanchez F, Ayats J, Gimenez M, Saballs P, Fridkin SK, Morgan J, Rodriguez-Tudela JL, Warnock DW, Pahissa A (2005) Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 43:1829-1835
23. Colombo AL, Nucci M, Park BJ, Nouer SA, Arthington-Skaggs B, da Matta DA, Warnock D, Morgan J (2006) Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 44:2816-2823 (Pubitemid 44228575)
24. Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, Lichtenberg D, Chawla V, Young J, Hadley S (2008) Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis 46:1206-1213 (Pubitemid 351589904)
25. Moretti ML, Trabasso P, Lyra L, Fagnani R, Resende MR, de Oliveira Cardoso LG, Schreiber AZ (2013) Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil. Med Mycol 51:225-230
26. Rodriguez D, Almirante B, Cuenca-Estrella M, Rodriguez-Tudela JL, Mensa J, Ayats J, Sanchez F, Pahissa A (2010) Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain. Clin Microbiol Infect 16:1676-1682
27. Blanchard E, Lortholary O, Boukris-Sitbon K, Desnos-Ollivier M, Dromer F, Guillemot D (2011) Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France. Antimicrob Agents Chemother 55:5358-5361
28. Fournier P, Schwebel C, Maubon D, Vesin A, Lebeau B, Foroni L, Hamidfar-Roy R, Cornet M, Timsit JF, Pelloux H (2011) Antifungal use influences Candida species distribution and susceptibility in the intensive care unit. J Antimicrob Chemother 66:2880-2886
29. Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D, Grenouillet F, Cassaing S, Baixench MT, Bretagne S, Dromer F, Lortholary O (2012) Candida spp. with acquired echinocandin resistance, France, 2004-2010. Emerg Infect Dis 18:86-90
30. Alexander BD, Johnson MD, Pfeiffer CD, Jimenez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA (2013) Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56:1724-1732
31. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM (2009) Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 48:1695-1703
32. Munoz P, Giannella M, Fanciulli C, Guinea J, Valerio M, Rojas L, Rodriguez-Creixems M, Bouza E (2011) Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital. Clin Microbiol Infect 17:1538-1545
33. Slavin MA, Sorrell TC, Marriott D, Thursky KA, Nguyen Q, Ellis DH, Morrissey CO, Chen SC (2010) Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death. J Antimicrob Chemother 65:1042-1051
34. Kumar G, Kumar N, Taneja A, Kaleekal T, Tarima S, McGinley E, Jimenez E, Mohan A, Khan RA, Whittle J, Jacobs E, Nanchal R (2011) Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest 140:1223-1231
35. Williams TA, Ho KM, Dobb GJ, Finn JC, Knuiman MW, Webb SA (2010) Changes in case-mix and outcomes of critically ill patients in an Australian tertiary intensive care unit. Anaesth Intensive Care 38:703-709
36. Gaieski DF, Edwards JM, Kallan MJ, Carr BG (2013) Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 41:1167-1174
37. Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ (2014) Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis. Crit Care Med 42:625-631
38. Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, Sobel JD, Pappas PG, Kullberg BJ (2012) Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 54:1110-1122
39. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT (2006) Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43:25-31 (Pubitemid 43939072)
40. Zilberberg MD, Kollef MH, Arnold H, Labelle A, Micek ST, Kothari S, Shorr AF (2010) Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis 10:150
41. Labelle AJ, Micek ST, Roubinian N, Kollef MH (2008) Treatment-related risk factors for hospital mortality in Candida bloodstream infections. Crit Care Med 36:2967-2972
42. Pai MP, Turpin RS, Garey KW (2007) Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia. Antimicrob Agents Chemother 51:35-39 (Pubitemid 46047684)